title: Docking of linear peptide antagonists into the human V(1a) vasopressin receptor. Identification of binding domains by photoaffinity labeling.
abstract: A novel photoactivatable linear peptide antagonist selective for the V(1a) vasopressin receptor, [(125)I][Lys(3N(3) Phpa)(8)]HO-LVA, was synthesized, characterized, and used to photolabel the human receptor expressed in Chinese hamster ovary cells. Two specific glycosylated protein species at 85-90 and 46 kDa were covalently labeled, a result identical to that obtained with a previous photosensitive ligand, [(125)I]3N(3)Phpa-LVA (Phalipou, S., Cotte, N. , Carnazzi, E., Seyer, R., Mahe, E., Jard, S., Barberis, C., and Mouillac, B. (1997) J. Biol. Chem. 272, 26536-26544). To identify contact sites between the new photoreactive analogue and the V(1a) receptor, the labeled receptors were digested with Lys-C or Asp-N endoproteinases and chemically cleaved with CNBr. Fragmentation with CNBr, Lyc-C, and Asp-N used alone or in combination, led to the identification of a restricted receptor region spanning the first extracellular loop. The results established that sequence Asp(112)-Pro(120) could be considered as the smallest covalently labeled fragment with [(125)I][Lys(3N(3)Phpa)(8)]HO-LVA. Based on the present experimental result and on previous photoaffinity labeling data obtained with [(125)I]3N(3)Phpa-LVA (covalent attachment to transmembrane domain VII), three-dimensional models of the antagonist-bound receptors were constructed and then verified by site-directed mutagenesis studies. Strikingly, these two linear peptide antagonists, when bound to the V(1a) receptor, could adopt a pseudocyclic conformation similar to that of the cyclic agonists. Despite divergent functional properties, these peptide antagonists could interact with a transmembrane-binding site significantly overlapping that of the natural hormone vasopressin.
authors.affiliation: U469 INSERM, CCIPE, 141 rue de la Cardonille, 34094 Montpellier cedex 5, France.
authors.forename: S
authors.initials: S
authors.lastname: Phalipou
authors.forename: R
authors.initials: R
authors.lastname: Seyer
authors.forename: N
authors.initials: N
authors.lastname: Cotte
authors.forename: C
authors.initials: C
authors.lastname: Breton
authors.forename: C
authors.initials: C
authors.lastname: Barberis
authors.forename: M
authors.initials: M
authors.lastname: Hibert
authors.forename: B
authors.initials: B
authors.lastname: Mouillac
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001665:Binding Sites; D016466:CHO Cells; D006224:Cricetinae; D006031:Glycosylation; D006801:Humans; D006868:Hydrolysis; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010455:Peptides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D019920:Photoaffinity Labels; D011869:Radioligand Assay; D017483:Receptors, Vasopressin / Q000378:metabolism
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D010455:Peptides; D019920:Photoaffinity Labels; D017483:Receptors, Vasopressin